Dipòsit Digital de Documents de la UAB
Publicación
Artículo científico (JournalArticle)
ISOTOPE, ISOform-guided prediction of epiTOPEs in cancer
Immunotherapies provide effective treatments for previously untreatable tumors and identifying tumor-specific epitopes can help elucidate the molecular determinants of therapy response. Here, we describe a pipeline, ISOTOPE (ISOform-guided prediction of epiTOPEs In Cancer), for the comprehensive identification of tumor-specific splicing-derived epitopes. Using RNA sequencing and mass spectrometry for MHC-I associated proteins, ISOTOPE identified neoepitopes from tumor-specific splicing events that are potentially presented by MHC-I complexes. Analysis of multiple samples indicates that splicing alterations may affect the production of self-epitopes and generate more candidate neoepitopes than somatic mutations. Although there was no difference in the number of splicing-derived neoepitopes between responders and non-responders to immune therapy, higher MHC-I binding affinity was associated with a positive response. Our analyses highlight the diversity of the immunogenic impacts of tumor-specific splicing alterations and the importance of studying splicing alterations to fully characterize tumors in the context of immunotherapies. ISOTOPE is available at https://github.com/comprna/ISOTOPE.
Proyecto:
Agència de Gestió d'Ajuts Universitaris i de Recerca 2017/SGR-1020
,
Agència de Gestió d'Ajuts Universitaris i de Recerca 2017/SGR-00519
,
Agencia Estatal de Investigación BIO2017-85364-R
,
Agencia Estatal de Investigación CEX2018-000782-M
,
Instituto de Salud Carlos III FI18/00034
,
Instituto de Salud Carlos III PT17/0009/0014